Long-term outcomes with as-needed aflibercept in diabetic macular oedema: 2-year outcomes of the ENDURANCE extension study | British Journal of Ophthalmology

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via AAO

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

Clinical science

Long-term outcomes with as-needed aflibercept in diabetic macular oedema: 2-year outcomes of the ENDURANCE extension study

Online download statistics by month:

Online download statistics by month: August 2017 to April 2023

	Abstract	Full	Pdf
Aug 2017	828	103	104
Sep 2017	735	91	103
Oct 2017	388	26	24
Nov 2017	194	33	22
Dec 2017	153	44	20
Jan 2018	136	28	18
Feb 2018	139	35	15
Mar 2018	154	45	23
Apr 2018	459	80	50
May 2018	572	105	61
Jun 2018	267	74	43
Jul 2018	249	73	27
Aug 2018	159	54	14
Sep 2018	120	46	11
Oct 2018	134	24	11
Nov 2018	107	27	12
Dec 2018	95	23	8
Jan 2019	91	15	4
Feb 2019	99	26	13
Mar 2019	60	9	9
Apr 2019	78	11	10
May 2019	78	18	8
Jun 2019	93	25	10
Jul 2019	106	27	25
Aug 2019	90	25	9
Sep 2019	85	22	11
Oct 2019	74	16	9
Nov 2019	78	18	6
Dec 2019	58	18	6
Jan 2020	57	23	7
Feb 2020	90	23	4
Mar 2020	115	23	14
Apr 2020	115	21	4
May 2020	58	25	6
Jun 2020	141	17	12
Jul 2020	99	22	10
Aug 2020	59	19	4
Sep 2020	109	19	12
Oct 2020	52	19	5
Nov 2020	81	6	9
Dec 2020	121	8	7
Jan 2021	51	8	7
Feb 2021	185	16	20
Mar 2021	96	15	11
Apr 2021	70	9	8
May 2021	38	7	20
Jun 2021	5	5	6
Jul 2021	9	5	9
Aug 2021	25	14	18
Sep 2021	25	22	11
Oct 2021	63	9	9
Nov 2021	104	11	8
Dec 2021	41	4	10
Jan 2022	52	7	8
Feb 2022	72	8	5
Mar 2022	91	15	10
Apr 2022	65	3	2
May 2022	90	12	10
Jun 2022	122	12	8
Jul 2022	91	10	8
Aug 2022	159	12	11
Sep 2022	146	18	17
Oct 2022	76	17	5
Nov 2022	50	9	6
Dec 2022	105	9	6
Jan 2023	66	11	8
Feb 2023	96	13	10
Mar 2023	68	20	19
Apr 2023	81	10	7
Total	9118	1677	1057